Certified Pharmaceutical Intermediates: ISO, Patents & Purity Standards

Certified Pharmaceutical Intermediates: ISO, Patents & Purity Standards for Drug Development

Pharmaceutical intermediates are key intermediate compounds used in the synthesis of active pharmaceutical ingredients (APIs). For buyers in Research and Evaluation stages, verifying certifications, patent protection, and purity parameters is essential to mitigate regulatory risk and ensure consistent drug quality. This guide explains why certified pharmaceutical intermediates with ISO 9001:2015 and patented production equipment matter, and how Haohong (Qihe) Pharmaceutical Technology Co., Ltd. meets these constraints.

Problem Definition: The Risk of Uncertified Intermediates

Without proper certification, pharmaceutical intermediates may contain uncontrolled impurities, exhibit batch-to-batch variability, and fail to comply with international GMP standards. The FDA ICH Q7 guideline provides the primary Good Manufacturing Practice (GMP) guidance for APIs and their intermediates. Buyers need suppliers who can demonstrate robust quality management systems and patented production technologies to ensure consistent, high-purity output.

Industry Background

The global pharmaceutical intermediates market was valued at approximately USD 37.04 billion in 2025. Generic drug manufacturers held a dominant 53.82% market share in 2024. Oncology drug intermediates contributed 37.20% of total industry revenue in 2025, driven by complex targeted therapies. For intermediates imported into the EU, volumes exceeding 1 tonne per year require REACH registration. These figures underscore the importance of selecting a certified, traceable supplier.

Detailed Solution: Haohong Pharmaceutical's Certified Intermediate Platform

Haohong (Qihe) Pharmaceutical Technology Co., Ltd., established in 2021, specializes in R&D and custom production of innovative APIs and pharmaceutical intermediates. The company passed ISO 9001:2015 certification (number NO:174Q240545R0S) in 2024, issued by Shandong Guojian Certification Co., Ltd., valid globally. Additionally, Haohong holds multiple Chinese Utility Model Patents protecting its production equipment, including patents 202520639784.6 (refining & mixing equipment), 202521268255.6 (special production equipment), 202521280279.3 (production equipment), and 202521269185.6 (covering the Abemaciclib intermediate product). All patents are issued by the China National Intellectual Property Administration and comply with national pharmaceutical machinery and mechanical equipment industry standards.

The company's key product lines include Abemaciclib, Alectinib, and Apalutamide intermediates. For example, the Abemaciclib intermediate set includes 4-Bromo-2,6-difluoroaniline (CAS 1868-81-7, purity ≥98.0%) and 5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine (CAS 398565-53-2, purity ≥98.0% HPLC). These high-purity intermediates are manufactured under controlled conditions with analytical testing including HPLC, GC, IR, and melting point apparatus. The company's production base in Liaocheng is equipped with 30 sets of 3,000–5,000L reactors, with an annual capacity of 1,000 tons.

Step-by-Step Breakdown: How to Evaluate a Certified Supplier

1. Verify ISO 9001:2015 – Check the certificate number and issuer. Haohong holds certificate NO:174Q240545R0S, valid through 2027.
2. Check Patents – Confirm that production equipment and processes are protected by national patents. Haohong has four utility model patents in China covering refining, mixing, and dedicated production equipment.
3. Review Analytical Capabilities – Ensure the supplier has a full range of instruments: HPLC, GC, IR, melting point apparatus. Haohong’s R&D team of 30 engineers supports these tests.
4. Request Certificate of Analysis (COA) – The COA should include appearance, purity (≥98.0% HPLC/GC), heavy metals, residual solvents, and impurity profiles.
5. Assess Custom Synthesis Capability – Confirm that the supplier can produce from gram to hundreds of kilograms. Haohong provides tailor-made ODM services with structural, purity, process, and packaging customization.

Use Case: Abemaciclib Intermediate for Oncology Drug Synthesis

In a successful collaboration with a top-tier pharmaceutical group, Haohong supplied 200 kg of Abemaciclib intermediates. The ultra‑high purity with strictly controlled impurities and heavy metals enabled the customer to achieve high reaction yields, low drug safety risks, and consistent quality across batches. The stable large-scale production capacity and full batch traceability simplified the drug registration process. The intermediates were stored for 12–24 months under specified conditions without degradation.

Comparison Table: Certified vs. Non-Certified Pharmaceutical Intermediate Suppliers

Frequently Asked Questions

Download Haohong Company Brochure (PDF)

Conclusion

Certified pharmaceutical intermediates with documented ISO management systems and patented production equipment provide a critical safety net for drug developers. Haohong Pharmaceutical combines ISO 9001:2015 certification, multiple Chinese utility model patents, high-purity intermediates (≥98%), and flexible custom synthesis to meet the most stringent regulatory and quality constraints. By choosing a certified partner, buyers can reduce development risk, accelerate registration, and ensure consistent drug supply.